← FDA DRUG APPROVALS

FDA NDA · NDA000734

HISTAMINE PHOSPHATE

Sponsor: LILLY

APPLICATION
NDA000734
TYPE
NDA
ORIGINAL APPROVAL
1939-04-25
LATEST ACTION
1980-08-13
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

HISTAMINE PHOSPHATEDiscontinued
HISTAMINE PHOSPHATE EQ 0.1MG BASE/ML · INJECTABLE · INJECTION
HISTAMINE PHOSPHATEDiscontinued
HISTAMINE PHOSPHATE EQ 1MG BASE/ML · INJECTABLE · INJECTION
HISTAMINE PHOSPHATEDiscontinued
HISTAMINE PHOSPHATE EQ 0.2MG BASE/ML · INJECTABLE · INJECTION

Approval history

1980-08-13Manufacturing (CMC) · Supplement 8AP
1939-04-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →